Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials

BACKGROUND: Complementary medicines (CM) are frequently used by patients with cancer. Controversy exists over the effectiveness and risk that CM may add to conventional cancer therapy. The incidence of CM use among patients enrolled in phase III clinical trials is unknown. METHODS: Medication lists...

Descripción completa

Detalles Bibliográficos
Autores principales: Wells, J Connor, Sidhu, Aven, Ding, Keyue, Smoragiewicz, Martin, Heng, Daniel Y C, Shepherd, Frances A, Ellis, Peter M, Bradbury, Penelope A, Jonker, Derek J, Siu, Lillian L, Gelmon, Karen A, Karapetis, Christos, Shapiro, Jeremy, Nott, Louise, O’Callaghan, Christopher J, Parulekar, Wendy R, Seymour, Lesley, Monzon, Jose G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914495/
https://www.ncbi.nlm.nih.gov/pubmed/35274718
http://dx.doi.org/10.1093/oncolo/oyac020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914495/
https://www.ncbi.nlm.nih.gov/pubmed/35274718
http://dx.doi.org/10.1093/oncolo/oyac020

Ejemplares similares